Search

Your search keyword '"Nout, Remi A"' showing total 297 results

Search Constraints

Start Over You searched for: Author "Nout, Remi A" Remove constraint Author: "Nout, Remi A" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
297 results on '"Nout, Remi A"'

Search Results

1. Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial

2. Automated causal inference in application to randomized controlled clinical trials

3. Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

4. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials

8. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*

9. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation

10. Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE

11. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

14. Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study

17. Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer

18. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors

19. GEC-ESTRO (ACROP)–ABS–CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina

20. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts

21. Prediction of recurrence risk in endometrial cancer with multimodal deep learning

25. Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study

26. Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study

29. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

30. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future

32. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy

34. Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy

38. HECTOR: multimodal deep learning predicts recurrence risk in endometrial cancer.

39. SO019LBA/#875 Molecular features predicts outcomes in multicentric international study of chemoradiation and MRI based image guided brachytherapy for cervical cancer (EMBRACE): final analysis from bioembrace-I

40. SO006/#55 Regular dilation and/or sexual activity show less risk for vaginal stenosis in cervical cancer patients

42. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, -2 and -3 trials

44. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas

45. 127 Impact of Brachytherapy Applicator on Clinical Outcomes in Cervix Cancer: An EMBRACE-I Study Analysis

46. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023

47. 3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer

49. 2293: Acute gastrointestinal toxicity of concurrent chemoradiation in cervix cancer: EMBRACE-II findings

Catalog

Books, media, physical & digital resources